Frontier Investment Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$448K Sell
8,107
-906
-10% -$48K 0.03% 169
2020
Q1
$436K Buy
9,013
+177
+2% +$9.13K 0.03% 151
2019
Q4
$468K Buy
8,836
+2,098
+31% +$115K 0.03% 183
2019
Q3
$371K Buy
6,738
+1,031
+18% +$57K 0.02% 179
2019
Q2
$325K Buy
5,707
+149
+3% +$8.06K 0.02% 190
2019
Q1
$299K Buy
5,558
+748
+16% +$38.1K 0.02% 201
2018
Q4
$217K Buy
+4,810
New +$231K 0.02% 222
2015
Q1
Sell
-46,926
Closed -$2.1M 187
2014
Q4
$2.1M Buy
46,926
+4,474
+11% +$182K 0.36% 54
2014
Q3
$1.63M Sell
42,452
-25
-0.1% -$1.01K 0.26% 66
2014
Q2
$1.72M Sell
42,477
-3,268
-7% -$134K 0.27% 58
2014
Q1
$1.86M Buy
45,745
+710
+2% +$27K 0.33% 57
2013
Q4
$1.72M Sell
45,035
-4,105
-8% -$141K 0.32% 53
2013
Q3
$1.6M Buy
49,140
+6,340
+15% +$206K 0.29% 54
2013
Q2
$1.31M Buy
+42,800
New +$1.42M 0.26% 60

Other funds holding ORCL

Frontier Investment Management's ORCL Position: Q2 2020 in Review

Frontier Investment Management reduced its Oracle (ORCL) stake by 10% in Q2 2020, selling an estimated $48K and leaving 8,107 shares worth $448K. The position accounts for 0.03% of the portfolio, ranked #169.

Frontier Investment Management first reported a position in ORCL in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.1M in Q4 2014. 1,822 funds tracked by Wall St. Rank hold ORCL as of Q2 2020.

  • Frontier Investment Management held 8,107 shares of Oracle worth $448K as of Q2 2020.
  • Frontier Investment Management sold 906 Oracle shares in Q2 2020, an estimated $48K.
  • Oracle made up 0.03% of Frontier Investment Management's portfolio in Q2 2020, its #169 holding.
  • Frontier Investment Management first reported a position in Oracle in Q2 2013 and has held it in 14 quarters since.
  • Frontier Investment Management's Oracle position peaked at $2.1M in Q4 2014.
  • 1,822 funds tracked by Wall St. Rank held Oracle as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.